A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

Condition:   Head Lice Interventions:   Drug: Ivermectin 0.5% Topical Application Lotion;   Drug: Ivermectin 0.5% Topical Application Lotion [SKLICE];   Drug: Placebo 0% Lotion Sponsor:   bioRASI, LLC Recruiting

Source: ClinicalTrials.gov - November 9, 2017 Category: Research Source Type: clinical trials